LEADER 01806nam  2200553   450 
001 9910824217803321
005 20200520144314.0
010   $a1-60805-896-4
035   $a(CKB)2560000000337924
035   $a(EBL)2048558
035   $a(SSID)ssj0001536851
035   $a(PQKBManifestationID)11869868
035   $a(PQKBTitleCode)TC0001536851
035   $a(PQKBWorkID)11510893
035   $a(PQKB)10248780
035   $a(MiAaPQ)EBC2048558
035   $a(Au-PeEL)EBL2048558
035   $a(CaPaEBR)ebr11054741
035   $a(OCoLC)939554523
035   $a(EXLCZ)992560000000337924
100   $a20150527h20152015  uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aFrontiers in Clinical Drug Research$hVolume 1$iHIV /$feditor, Atta-ur-Rahman
210  1$aSharjah, United Arab Emirates :$cBentham Science Publishers,$d2015.
210  4$d2015
215   $a1 online resource (300 p.)
225 1 $aFrontiers in Clinical Drug Research-HIV, 1
300   $aDescription based upon print version of record.
311   $a1-60805-897-2 
320   $aIncludes bibliographical references and index.
327   $aCover ; Title Page; EUL; Contents; Preface; List of Contributors; Chapter 01; Chapter 02; Chapter 03; Chapter 04; Chapter 05; Chapter 06; Chapter 07; Index ; Back Cover
410  0$aFrontiers in Clinical Drug Research-HIV, 1
606   $aAIDS (Disease)
606   $aHIV infections
615  0$aAIDS (Disease)
615  0$aHIV infections.
676   $a616.9792
702   $aAtta-ur-Rahman
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910824217803321
996   $aFrontiers in clinical drug research$93912710
997   $aUNINA